Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
retinol + ergocalciferol
- Development stage
- Unknown
- Lead developer
- Offenbach Farmacéutica Mexicana
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Adekals is an oral vitamin supplement containing a combination of retinol (vitamin A) and ergocalciferol (vitamin D2). Developed and manufactured by Offenbach Farmacéutica Mexicana, it is indicated for the prevention and treatment of vitamin A and D deficiencies, supporting bone metabolism, immune function, cellular growth, and visual health. It is formulated as an oral solution.
- Brand names
- Adekals
- Other names
- retinol + vitamin d2vitamin a + vitamin d2
02
Targets
RXRA (Retinoid X receptor alpha)RARA (Retinoic acid receptor alpha)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on retinol + ergocalciferol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on retinol + ergocalciferol.